drugset / Trial / NCT01459146
Artemisinin-based Combination Therapy-Intermittent Preventive Treatment (ACT-IPT) Trial Among Schoolchildren in Kassena-Nankana, Ghana
Phase 4
Unknown
345 enrolled
Navrongo Health Research Centre, Ghana
DBL -Institute for Health Research and Development · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to determine if Artemisinin-based Combination Therapy, ACT,(artemether-lumefantrine) used as intermittent preventive treatment (IPT) alone or in combination with praziquantel, will have any effects on anemia, malaria, schistosomiasis and school sustained attention and concentration.
Timeline
- Start
- 2010-12
- Primary completion
- 2011-10
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Albendazole | Small molecule | 400 mg | Oral |
| Subject | Artemether-lumefantrine | Unknown | 20 mg | Oral |
| Subject | Artemether-lumefantrine | Unknown | 120 mg | Oral |
| Comparator | Praziquantel | Small molecule | 40 mg/kg | Oral |